Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1056/NEJMoa054013

http://scihub22266oqcxt.onion/10.1056/NEJMoa054013
suck pdf from google scholar
16554528!ä!16554528

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid16554528      N+Engl+J+Med 2006 ; 354 (12): 1264-72
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Sequence variations in PCSK9, low LDL, and protection against coronary heart disease #MMPMID16554528
  • Cohen JC; Boerwinkle E; Mosley TH Jr; Hobbs HH
  • N Engl J Med 2006[Mar]; 354 (12): 1264-72 PMID16554528show ga
  • BACKGROUND: A low plasma level of low-density lipoprotein (LDL) cholesterol is associated with reduced risk of coronary heart disease (CHD), but the effect of lifelong reductions in plasma LDL cholesterol is not known. We examined the effect of DNA-sequence variations that reduce plasma levels of LDL cholesterol on the incidence of coronary events in a large population. METHODS: We compared the incidence of CHD (myocardial infarction, fatal CHD, or coronary revascularization) over a 15-year interval in the Atherosclerosis Risk in Communities study according to the presence or absence of sequence variants in the proprotein convertase subtilisin/kexin type 9 serine protease gene (PCSK9) that are associated with reduced plasma levels of LDL cholesterol. RESULTS: Of the 3363 black subjects examined, 2.6 percent had nonsense mutations in PCSK9; these mutations were associated with a 28 percent reduction in mean LDL cholesterol and an 88 percent reduction in the risk of CHD (P=0.008 for the reduction; hazard ratio, 0.11; 95 percent confidence interval, 0.02 to 0.81; P=0.03). Of the 9524 white subjects examined, 3.2 percent had a sequence variation in PCSK9 that was associated with a 15 percent reduction in LDL cholesterol and a 47 percent reduction in the risk of CHD (hazard ratio, 0.50; 95 percent confidence interval, 0.32 to 0.79; P=0.003). CONCLUSIONS: These data indicate that moderate lifelong reduction in the plasma level of LDL cholesterol is associated with a substantial reduction in the incidence of coronary events, even in populations with a high prevalence of non-lipid-related cardiovascular risk factors.
  • |*Codon, Nonsense[MESH]
  • |*Genetic Variation[MESH]
  • |Black People/genetics[MESH]
  • |Carotid Arteries/anatomy & histology[MESH]
  • |Cholesterol, LDL/*blood[MESH]
  • |Cohort Studies[MESH]
  • |Coronary Disease/blood/epidemiology/*genetics[MESH]
  • |Female[MESH]
  • |Gene Frequency[MESH]
  • |Genotype[MESH]
  • |Humans[MESH]
  • |Hypolipoproteinemias/*genetics[MESH]
  • |Incidence[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Proportional Hazards Models[MESH]
  • |Proprotein Convertase 9[MESH]
  • |Proprotein Convertases[MESH]
  • |Risk[MESH]
  • |Serine Endopeptidases/*genetics[MESH]
  • |United States[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box